Intrinsiqq
BridgeBio Oncology Therapeutics, Inc. logo

BridgeBio Oncology Therapeutics, Inc.

BBOT

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$145M
EPS-$614.32
P/E-0.00
P/FCF-0.96
EV/EBITDA0.25
FCF Yield–
Div. Yield–
Net Debt/FCF1.3x
BridgeBio Oncology Therapeutics, Inc. intrinsic value
52-Week Range
$1.81$5.05

Profitability & Returns

Revenue

N/A

Net Income (TTM)

-$172M

▼ -80.5% YoY

Op. Margin

–

ROIC

-41.93%

▲ +23044.2pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-$151M

▼ -107.9% YoY

Op. Cash Flow (TTM)

-$151M

▼ -107.0% YoY

Net Debt

-$191M

Net Cash Position

Cash & Equiv.

$194M

Continue Research

Peers

Pharmaceutical Preparations · Pick stocks to compare with BBOT

CompareIntrinsic value
GANXGain Therapeutics Inc.
$1.00-4.86%25
KURAKura Oncology Inc.
$6.91-5.99%10
IRDOpus Genetics Inc.
$3.99-2.21%10
PVCTProvectus Biopharmaceuticals, Inc.
$0.05+1.11%6
VSTMVerastem Inc.
$6.33-7.73%40
LXRXLexicon Pharmaceuticals, Inc.
$1.53-8.38%40
COLLCollegium Pharmaceutical Inc.
$24.72-1.94%85
SVRASavara Inc.
$4.26-18.23%10

Held by ETFs

BBOT is in 7 US ETFs. The largest of them, with BBOT's weight in each:

BridgeBio Oncology Therapeutics (BBOT) in two numbers

Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-0.00
Negative: a loss over the last twelve months. Price to free cash flow -0.96.
Financials

Questions about BridgeBio Oncology Therapeutics

Does BridgeBio Oncology Therapeutics (BBOT) pay a dividend?

No. BridgeBio Oncology Therapeutics (BBOT) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 5 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in BBOT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing BBOT

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.